Neurofibromin, the neurofibromatosis type 1 RaS-GAP, is required for appropriate P0 expression and myelination

Annals of the New York Academy of Sciences

Volumn 883, Issue , 1999, Pages 203-214

  Rosenbaum, Thorsten ^a,b   Kim, Haesun A ^a,c   Boissy, Ying L ^a   Ling, Bo ^a   Ratner, Nancy ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN; NEUROFIBROMIN; PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MOUSE; MOUSE MUTANT; MYELIN SHEATH; NERVE CELL; NERVE FIBER; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; SCHWANN CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE;

ANIMALS; AXONS; FEMALE; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; GENES, NEUROFIBROMATOSIS 1; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELIN P0 PROTEIN; MYELIN SHEATH; NEUROFIBROMIN 1; NEURONS; ORGAN CULTURE TECHNIQUES; PROTEINS; SCHWANN CELLS; SIGNAL TRANSDUCTION;

EID: 0033554310     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08583.x     Document Type: Article

References (52)

1. AGUAYO, A.J., J. EPPS, L. CHARRON & G.M. BRAY. 1976. Multipotentiality of Schwann cells in cross anastomosed and grafted myelinated and unmyelinated nerves: quantitative microscopy and radioautography. Brain Res. 104; 1-20.
2. DEWAEGH, S.M., V.M.-Y. LEE & S.T. BRADY. 1992. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68: 451-463.
3. BUNGE, M.B., R.P. BUNGE, D.J. CAREY, C.J. CORNBROOKS, C.F. ELDRIDGE, A.K. WILLIAMS & P.M. WOOD. 1983. Axonal and nonaxonal influences on Schwann cells development. In Development and Regenerating Vertebrate Nervous Systems. P.W. Coates, R.R. Markwald & A.D. Kenny, Eds.: 71-105. Liss. New York.
4. ELDRIDGE, C.F., M.B. BUNGE, R.P. BUNGE & P.M. WOOD. 1987. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J. Cell Biol. 105: 1023-1034.
5. FERNANDEZ-VALLE, C., N. FREGIEN, P.M. WOOD & M.B. BUNGE. 1993. Expression of the protein zero myelin gene in axonrelated Schwann cells is linked to basal lamina formation. Development 119; 867-880.
6. BOKOCH G.M. & C.J. DER. 1993. Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J. 7: 750-759.
7. RIDLEY, A.J., H.F. PATERSON, M. NOBLE & H. LAND. 1988. Rasmediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 7: 1635-1645.
8. KIM, H.A., T. ROSENBAUM, M.A. MARCHIONNI, N. RATNER & J.E. DECLUE. 1995. Schwann cells from neurofibromin deficient mice exhibit activation of p 21ras, inhibition of cell proliferation and morphological changes. Oncogens 11: 325-335.
9. WU, K., Y. HUAN, D.H. GUTMANN, J.L. RUTKOWSKI & G.I. TENNEKOON. 1995. Activating the Ras pathway induces Schwann cell differentiation [abstract], Soc. Neurosci. 21: 322a.
10. KIM, M.R. & F. TAMANOI. 1998. Neurofibromatosis 1 GTPase activating protein-related domain and its functional significance. In Neurofibromatosis Type 1 : From Genotype to Phenotype. M. Upadhyaya & D.N. Cooper, Eds.; 89-112. BIOS. Oxford, U.K.
11. STEFANSSON, K., R. WOLLMANN & M. JERKOVIC. 1982. S100 protein in soft tissue tumors derived from Schwann cells and melanocytes. Am. J. Pathol. 106: 261-268.
12. PELTONEN, J., S. JAAKOLA & M. LEBWOHL. 1988. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab. Invest. 59: 760-771.
13. SHEELA, S., V.M. RICCARDI & N. RATNFR. 1990. Angiogenic and invasive properties of neurofibroma Schwann cells. J. Cell Biol. 11: 645-653.
14. ROSENBAUM, T., K.M. PATRIE & N. RATNER. 1997. Neurofibromatosis type 1: Genetic and cellular mechanisms of peripheral nerve tumor formation. Neuroscientist 3: 412-420.
15. BASU, T.N., D.H. GUTMANN, J.A. FLETCHER, T.W. GLOVER, F.S. COLLINS & J. DOWNWARD. 1992. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 713-715.
16. DECLUE, J.E., A.G. PAPAGEORGE, J.A. FLETCHER, S.R. DIEHL, N. RATNER, W. VASS & D. LOWY. 1992. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69: 265-273.
17. GUHA, A., N. LAU, I. HUVAR, D. GUTMANN, J. PROVIAS, T. PAWSON & G. BOSS. 1996. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12: 507-513.
18. DASTON, M. & N, RATNER. 1992 Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev. Dyn. 195: 216-226.
19. WRABETZ, L., M.L. FELTRI, H. KIM, M. DASTON, J. KAMHOLZ, S. SCHERER & N. RATNER. 1995. Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells. Glia 15: 22-32.
20. DASTON, M.M., H. SCRABLE, M. NORDLUND, A.K. STURBAUM, L.M. NISSEN & N. RATNER. 1992. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 8: 415-428.
21. BRANNAN, C.I., A.S. PERKINS, K.S. VOGEL, N. RATNER, M.L. NORDLUND, S.W. REID, A.M. BUCHBERG, N.A. JENKINS, L.F. PARADA & N.G. COPELAND. 1994. Targeted disruption of the neurofibromatosis type 1 gene leads to developmental abnormalities in heart and various neural crestderived tissues. Genes Dev. 8: 1019-1029.
22. JACKS, T., T.S. SHIH, E.M. SCHMTTT, R.T. BRONSON, A. BERNARDS & R.A. WEINBERG. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1, Nature Genet. 7: 353-361.
23. TRAPP, B.D., P. HAUER & G. LEMKE. 1988. Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells. J. Neurosci. 8: 3515-3521.
24. LEMKE, G. & M. CHAO. 1988. Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Development 102: 499-504.
25. 1 NCAM, NGFreceptor) depends on growth inhibition. J. Cell Biol. 112: 457-467.
26. 0 mRNA and protein induction in cultured Schwann cells by FGF2 and TGFb1, TGFb2 and TGFb3. Development 120: 1399-1409.
27. KIM, H.A., B. LING & N. RATNER. 1997b. Nf1-deficient mouse Schwann cells are angiogenic, invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol. Cell. Biol. 17: 862-872.
28. DUNCAN, D. 1934. A relation between axon diameter and myelination determined by measurement of myelinated spinal root fibers. J. Comp. Neurol. 60: 437.
29. FRIEDE, R.L. 1972. Control of myelin formation by axon caliber (with a model of the control mechanism). J. Comp. Neurol. 144: 233-252.
30. MATTHEWS, M.A. 1968. An electron microscopic study of the relationship between axon diameter and the initiation of myelin production in the peripheral nervous system. Anat. Rec. 161: 337.
31. VOYVODIC, J.T. 1989. Target size regulates calibre and myelination of sympathetic axons. Nature 342; 430-433.
32. GUTMANN, D.H., G.I. TENNEKOON, J.L. COLE, F.S. COLLINS & J.L. RUTKOWSKI. 1993. Modulation of the Neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation. J. Neurosci. Res. 36: 216-223.
33. PLEASURE, J., B. KREIDER, S. SHUMAN & G. SOBUE, 1985. Tissue culture studies of Schwann cell proliferation and differentiation. Dev. Neurosci. 7: 364-373.
34. RAFE, M.C., A. HORNBY-SMITH & J.P. BROCKES. 1978. Cyclic AMP as a mitogenic signal for cultured rat Schwann cells. Nature (London) 273: 672-673.
35. SOBUE, G. & D. PLEASURE. 1984. Schwann cell galactocerebroside induced by derivatives of adenosine 3′, 5′ monophosphate. Science 224: 72-74.
36. COOK, S.J. & F. MCCORMICK. 1993. Inhibition by cAMP of Rasdependent activation of Raf. Science 262: 1069-1072.
37. KIM, H.A., J.E. DECLUE & N. RATNER. 1997. cAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin/tyrosine kinase pathways. J. Neurosci. Res. 49: 1-11.
38. JOHNSON, M.R., J.K. DECLUE, S. FELZMANN, W.C. VASS, G. XU, R. WHITE & D.R. LOWY, 1994. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol. Cell. Biol. 14: 641-645.
39. JOHNSON, M.R., A.T. LOOK, J.E. DECLUE, M.B. VALENTINE & D.R. LOWY. 1993. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP Ras. Proc. Natl. Acad. Sci. USA 90: 5539-5543.
40. QUO, H.-F, I. THE, F. HANNAN, A. BERNARDS & Y. ZHONG. 1997. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 276: 795-798.
41. ROSENBAUM, T., Y.L. BOISSY, K. KOMBRINCK, C. BRANNAN, N.A. JENKINS, N.G. COPELAND & N. RATNER, 1995. Neurofibromin deficient fibroblasts fail to form perineurium in vitro. Development. 121: 3583-3592.
42. BERMINGHAM JR., J.R., S.S. SCHERER, S. O'CONNELL, E. ARROYO, K. KALLA, F.R. POWELL & M.G. ROSENFELD. 1996. Tst-1/SCIP/Oct-6 regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev. 10: 1751-1762.
43. TOPILKO, P., S. SCHNEIDER-MAUNOURY, G. LEVI, A. BARON-VAN EVERCOOREN, B. YOUNES, A. CHENNOUFI, T. SEITANIDOU, C. BABINET & P. CHARNAY. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371: 796-799.
44. JAEGLE, M., W. MANDEMAKERS, L. BROOS, R. ZWART, A. KARIS, P. VISSER, F. GROSVELD & D. MEIER. 1996. The POU factor Oct-6 and Schwann cell differentiation. Science 273: 507-510.
45. VOGEL, K.S., C.I. BRANNAN, N.A. JENKINS, N.G COPELAND & L.F. PARADA. 1995. Loss of neurofibromin independent survival of embryonic sensory and sympathetic neurons. Cell 82: 733-742.
46. 0 expression and DNA synthesis by insulin-like growth factors in vitro. Eur. J. Neurosci. 8(3): 553-564.
47. EINHEBER, S., M.J. HANNOCKS, C.N. METZ, D.B. RIFKIN, & J.L. SALZER. 1995. Transforming growth factor-beta 1 regulates axon/Schwann cell interactions. J. Cell Biol. 129(2): 443-458.
48. GUENARD, V. L.A. GWYNN & P.M. WOOD. 1995. Transforming growth factor-beta blocks myelination but not ensheathment of axons by Schwann cells in vitro. J. Neurosci. 15(1 Pt 1): 419-428.
49. PELES, E., S.S. BACUS, R.A. KOSKI, H.S. LU, D. WEN, S.G. OGDEN, R.B. LEVY & Y. YARDEN. 1992. Isolation of the Neu/HER2 stimulatory ligand: a 44-kD glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205-216.
50. OBREMSKI, V.J., M.I. JOHNSON & M.B. BUNGE. 1993a. Fibroblasts are required for Schwann cell basal lamina deposition and ensheathment of unmyelinatcd sympathetic neurites in culture. J. Neurocytol. 22: 102-117.
51. BOTTENSTEIN, J. & G.H. SATO. 1979, Growth of a neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76: 514-517.
52. KIM, H.A. & N. RATNER. 1997. A procedure for isolating Schwann cells developed for analysis of the mouse embryonic lethal mutation NF1. In Cell Biology and Pathology of Myelin. B.H. Juurlink et al., eds.: 201-212. Plenum, New York.